CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.090
-0.220 (-9.52%)
Jul 9, 2025, 9:32 AM - Market open
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $24.12 million as of July 9, 2025. Its market cap has increased by 1.46% in one year.
Market Cap
24.12M
Enterprise Value
23.35M
1-Year Change
1.46%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $24.12M, a decrease of -47.70%. That is a compound annual growth rate of -25.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 26.66M | -32.06% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |